secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2024-02-20T23:59:59+00:00
Accession:  0001193805-24-000251
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics regains Nasdaq minimum bid price compliance; panel monitor for one year
--------------------------------------------------------------------------------

- Nasdaq notified Alaunos on Feb 16, 2024 that it has regained compliance with the $1.00 bid price requirement.
- All applicable criteria for continued listing are satisfied; the listing matter is closed.
- Subject to mandatory panel monitor under Nasdaq Rule 5815(d)(4)(B) through Feb 16, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119380524000251/0001193805-24-000251-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119380524000251/e619290_8k-at.htm
  HTML page:      https://secwatch.observer/filing/0001193805-24-000251

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer